Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIIb randomized double-blind placebo-controlled trial of GRAZAX grass pollen tablets
2006-005263-26Phase 3Completed
- Sponsor
- ALK-Abelló
- Start
- Mar 2012
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in allergic rhinitis (AR) comparing GRAZAX grass pollen tablet with Placebo (2 arms). Primary endpoints: Changes in immunological parameters and Changes in cutaneous reactivity. Started Mar 2012; status: completed.
02
Drugs
phleum pratense allergen extract
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on 2006-005263-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005263-26.